American International Group’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-12,389
Closed -$199K 2106
2024
Q1
$199K Sell
12,389
-106
-0.8% -$1.72K ﹤0.01% 2154
2023
Q4
$171K Sell
12,495
-51
-0.4% -$585 ﹤0.01% 2244
2023
Q3
$183K Buy
12,546
+446
+4% +$7.55K ﹤0.01% 2176
2023
Q2
$206K Buy
+12,100
New +$178K ﹤0.01% 2142
2022
Q2
Sell
-12,059
Closed -$102K 3233
2022
Q1
$102K Sell
12,059
-848
-7% -$7.82K ﹤0.01% 2588
2021
Q4
$155K Sell
12,907
-387
-3% -$5.9K ﹤0.01% 2511
2021
Q3
$236K Sell
13,294
-83
-0.6% -$1.57K ﹤0.01% 2333
2021
Q2
$274 Buy
+13,377
New +$264K ﹤0.01% 2311

Other funds holding RCEL

American International Group's RCEL Position: Q2 2024 in Review

American International Group sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 12,389 shares — an estimated $199K sold.

American International Group first reported a position in RCEL in Q2 2021 and held it in 8 quarters. The position peaked at $236K in Q3 2021. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • American International Group reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,389 Avita Medical shares in Q2 2024, an estimated $199K.
  • American International Group first reported a position in Avita Medical in Q2 2021 and held it in 8 quarters.
  • American International Group's Avita Medical position peaked at $236K in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.